Immune and inflammatory features associated with pyroptosis- and myocardial fibrosis-related genes in HFpEF: a machine learning study
- 1Department of Cardiology, Wuhan Fourth Hospital , ,
- 2Department of Ultrasound, Wuhan Fourth Hospital , ,
- 3Department of Neurosurgery, Wuhan Fourth Hospital , ,
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome marked by inflammation, immune dysregulation, and myocardial fibrosis. Whether pyroptosis intersects with fibrotic remodeling in HFpEF remains uncertain. Two murine cardiac transcriptomic datasets were integrated after batch correction and intersected with curated pyroptosis- and myocardial fibrosis-related gene sets. Functional enrichment, univariate logistic regression, support vector machine–recursive feature elimination (SVM-RFE), and least absolute shrinkage and selection operator (LASSO) regression were used for feature selection. Complete separation in the ordinary three-gene logistic fit prompted refitting with Firth bias-reduced logistic regression. Performance was assessed by apparent area under the curve (AUC), stratified bootstrap optimism correction, and repeated nested cross-validation; the panel was re-estimated in a human left-ventricular dataset for exploratory replication. Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) estimated immune-cell fractions, and expression was examined in a high-fat diet (HFD)/N ω -nitro-L-arginine methyl ester hydrochloride (L-NAME) murine model and whole blood from patients with HFpEF. Six candidates— Pparg , Ace2 , Smad2 , Lcn2 , Ptpn11 , and Sqstm1 —were identified. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses linked them to SMAD binding, autolysosome/amphisome activity, cellular senescence, efferocytosis, and renin-angiotensin signaling. In the 45-sample discovery cohort, the fixed Pparg - Ptpn11 - Ace2 Firth model had an apparent AUC of 1.0000; bootstrap correction yielded an AUC of 0.9971 (95% percentile interval, 0.9780–1.0000). Repeated nested cross-validation produced a mean out-of-fold AUC of 0.9286 (2.5%–97.5% percentile interval, 0.8726–0.9700), revealing additional feature-selection uncertainty. Re-estimation in the human dataset represented panel-level replication rather than validation of a locked cross-species model. No inferred immune-cell fraction differed between HFpEF and control after false-discovery-rate correction, although exploratory correlations were observed among deconvolved fractions and with Ptpn11 expression. HFD/L-NAME-treated mice developed diastolic dysfunction, reduced exercise capacity, pulmonary congestion, cardiomyocyte hypertrophy, and myocardial fibrosis despite preserved systolic function; myocardial Ptpn11 , Pparg , and Ace2 transcripts and their proteins were reduced. In patients with HFpEF, whole-blood PTPN11 mRNA was lower than in controls and inversely associated with N-terminal pro-B-type natriuretic peptide and C-reactive protein; these unadjusted findings remain exploratory. The three-gene panel is hypothesis-generating rather than a stable diagnostic model; its transportability, selection stability, and clinical relevance require prospective validation.
Related
- Xinfeng capsule regulates pyroptosis and ameliorates cardiac fibrosis in rheumatoid arthritis through lncRNA GAS5 and TLR4/ROS/miR-21 pathways
- Clinical, radiological, and pathological features of pulmonary hypertension associated with combined pulmonary fibrosis and emphysema.
- Adipose Tissue Pericellular Fibrosis, Weight Loss and Features of Metabolic Dysfunction-Associated Steatotic Liver Disease after Bariatric Surgery
- Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center
- Hydrogen sulfide attenuates post-myocardial infarction cardiac fibrosis by modulating SENP1-dependent TEAD1 SUMOylation
BibTeX
@article{gao2026immune,
title = {{Immune and inflammatory features associated with pyroptosis- and myocardial fibrosis-related genes in HFpEF: a machine learning study}},
author = {Bo Gao and Gang Wang and Zhi-qiang Xu and Ming Peng},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1925067},
url = {https://europepmc.org/article/PMC/PMC13672030},
note = {CC BY},
}
RIS
TY - JOUR
TI - Immune and inflammatory features associated with pyroptosis- and myocardial fibrosis-related genes in HFpEF: a machine learning study
AU - Bo Gao
AU - Gang Wang
AU - Zhi-qiang Xu
AU - Ming Peng
PY - 2026
DA - 2026/10/02
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1925067
UR - https://europepmc.org/article/PMC/PMC13672030
AB - Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome marked by inflammation, immune dysregulation, and myocardial fibrosis. Whether pyroptosis intersects with fibrotic remodeling in HFpEF remains uncertain. Two murine cardiac transcriptomic datasets were integrated after batch correction and intersected with curated pyroptosis- and myocardial fibrosis-related gene sets. Functional enrichment, univariate logistic regression, support vector machine–recursive feature elimination (SVM-RFE), and least absolute shrinkage and selection operator (LASSO) regression were used for feature selection. Complete separation in the ordinary three-gene logistic fit prompted refitting with Firth bias-reduced logistic regression. Performance was assessed by apparent area under the curve (AUC), stratified bootstrap optimism correction, and repeated nested cross-validation; the panel was re-estimated in a human left-ventricular dataset for exploratory replication. Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) estimated immune-cell fractions, and expression was examined in a high-fat diet (HFD)/N ω -nitro-L-arginine methyl ester hydrochloride (L-NAME) murine model and whole blood from patients with HFpEF. Six candidates— Pparg , Ace2 , Smad2 , Lcn2 , Ptpn11 , and Sqstm1 —were identified. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses linked them to SMAD binding, autolysosome/amphisome activity, cellular senescence, efferocytosis, and renin-angiotensin signaling. In the 45-sample discovery cohort, the fixed Pparg - Ptpn11 - Ace2 Firth model had an apparent AUC of 1.0000; bootstrap correction yielded an AUC of 0.9971 (95% percentile interval, 0.9780–1.0000). Repeated nested cross-validation produced a mean out-of-fold AUC of 0.9286 (2.5%–97.5% percentile interval, 0.8726–0.9700), revealing additional feature-selection uncertainty. Re-estimation in the human dataset represented panel-level replication rather than validation of a locked cross-species model. No inferred immune-cell fraction differed between HFpEF and control after false-discovery-rate correction, although exploratory correlations were observed among deconvolved fractions and with Ptpn11 expression. HFD/L-NAME-treated mice developed diastolic dysfunction, reduced exercise capacity, pulmonary congestion, cardiomyocyte hypertrophy, and myocardial fibrosis despite preserved systolic function; myocardial Ptpn11 , Pparg , and Ace2 transcripts and their proteins were reduced. In patients with HFpEF, whole-blood PTPN11 mRNA was lower than in controls and inversely associated with N-terminal pro-B-type natriuretic peptide and C-reactive protein; these unadjusted findings remain exploratory. The three-gene panel is hypothesis-generating rather than a stable diagnostic model; its transportability, selection stability, and clinical relevance require prospective validation.
SN - 1664-3224
ER -